Literature DB >> 23572047

Molecular cloning, sequencing, and biological characterization of GRA4 gene of Toxoplasma gondii.

Hira Ram1, J R Rao, A K Tewari, P S Banerjee, A K Sharma.   

Abstract

In the present study, GRA4 (dense granule antigen) gene of Toxoplasma gondii was cloned, sequenced, and biologically characterized. The nucleotide sequence data obtained were analyzed and submitted in GenBank database (accession no. EU660037). Analysis of nucleotide sequence of GRA4 gene revealed 99.2 % homology with the published sequence (accession no. M76432). The gene segment (open reading frame) of 1,054 bp was further amplified and re-cloned in expression vector pET-32a. The recombinant protein obtained following the expression in prokaryotic system had a molecular mass of approx. 50 kDa and showed good immunoreactivity with T. gondii sera collected from infected goats. The immunization study of the recombinant protein performed in laboratory mice and live challenge with T. gondii revealed a high level of IgG response against the tachyzoite lysate antigen (TLA) by an indirect ELISA. Protection against T. gondii challenge infection was not evident in immunized mice except for the prolongation of survival period by 2 days. Humoral immune response profile revealed initially a high level of IgG antibody, but at 1 week post-challenge, a sudden drop in the level of the antibody was appreciable. Cytokine profiling by enzyme-linked immunosorbent spot method revealed relatively high level of IFN-γ production by the rodent spleen cells followed by IL-10 and IL-4. Increase in IFN-γ production by spleen cells of immunized mice following TLA stimulation suggested direct correlation to the up-regulated Th1 cells. However, the present immunization trial failed to show any positive relationship with the protection of mice following T. gondii challenge infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23572047     DOI: 10.1007/s00436-013-3414-3

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  30 in total

1.  Functional analysis of Toxoplasma gondii protease inhibitor 1.

Authors:  Meredith Teilhet Morris; Alexandra Coppin; Stanislas Tomavo; Vern B Carruthers
Journal:  J Biol Chem       Date:  2002-09-11       Impact factor: 5.157

2.  Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis.

Authors:  M M Liu; Z G Yuan; G H Peng; D H Zhou; X H He; C Yan; C C Yin; Y He; R Q Lin; H Q Song; X Q Zhu
Journal:  Parasitol Res       Date:  2010-02-23       Impact factor: 2.289

3.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.

Authors:  R T Gazzinelli; F T Hakim; S Hieny; G M Shearer; A Sher
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

Review 4.  Vaccines against Toxoplasma gondii: challenges and opportunities.

Authors:  Erik Jongert; Craig W Roberts; Nicola Gargano; Elisabeth Förster-Waldl; Elisabeth Förster-Wald; Eskild Petersen
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

5.  Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection.

Authors:  N Debard; D Buzoni-Gatel; D Bout
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice.

Authors:  S J Parker; C W Roberts; J Alexander
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

7.  Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii.

Authors:  E Petersen; H V Nielsen; L Christiansen; J Spenter
Journal:  Vaccine       Date:  1998-08       Impact factor: 3.641

8.  Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii.

Authors:  R T Gazzinelli; M Wysocka; S Hayashi; E Y Denkers; S Hieny; P Caspar; G Trinchieri; A Sher
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

9.  DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice.

Authors:  Xi-Meng Sun; Jun Zou; Elashram Saeed A A; Wen-Chao Yan; Xian-Yong Liu; Xun Suo; Heng Wang; Qi-Jun Chen
Journal:  Parasit Vectors       Date:  2011-11-09       Impact factor: 3.876

Review 10.  Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis.

Authors:  Henryka Dlugonska
Journal:  J Biomed Biotechnol       Date:  2008
View more
  4 in total

1.  Immunization with excreted-secreted antigens reduces tissue cyst formation in pigs.

Authors:  Yanhua Wang; Delin Zhang; Guangxiang Wang; Hong Yin; Meng Wang
Journal:  Parasitol Res       Date:  2013-08-15       Impact factor: 2.289

2.  Cloning and expression of Toxoplasma gondii GRA-4 recombinant protein as a toxoplasmosis diagnostic kit candidate.

Authors:  Muhammad Hanafiah; Teuku Zahrial Helmi; Amalia Sutriana; Dwi Priyowidodo; Fihiruddin Fihiruddin
Journal:  Vet World       Date:  2020-10-05

3.  Analyzing and identifying novel B cell epitopes within Toxoplasma gondii GRA4.

Authors:  Yanhua Wang; Guangxiang Wang; Jiangtao Ou; Hong Yin; Delin Zhang
Journal:  Parasit Vectors       Date:  2014-10-10       Impact factor: 3.876

4.  Expression of Plasmid Encoded GRA4 Gene of Toxoplasma gondii RH Strain in CHO Eukaryotic Cells.

Authors:  Marjaneh Aghdasi; Fatemeh Ghaffarifar; Fatemeh Forooghi; Abdol Hossein Dalimi Asl; Zohre Sharifi; Nahid Maspi
Journal:  Iran J Parasitol       Date:  2018 Jul-Sep       Impact factor: 1.012

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.